Screening of nitrosamines by LC-HR-MS/MS technique – we detect trace amounts in active substances (APIs), products and raw materials.
LC-HR-MS/MS lipid identification with CID and EAD fragmentation. Precision lipidomics – accurate annotation, profiling and expert support.
Our specialized service based on LC-MS/MS technique enables precise identification of the chemical structure of impurities present in samples of raw materials, active substances and finished drug products.
Quantitative analysis of PQ500™ plasma proteins by LC-MS/MS – precision proteomics for diagnostics, biomarker analysis and clinical research.
Quantitative analysis of proteins by LC-MS/MS. Targeted proteomics, biomarker determination, clinical sample analysis and quality control.
Monoclonal antibody analysis by LC-HR-MS/MS – MAM – glycosylations, peptide maps, disulfide bridges, PTMs, TiPOS studies, etc.
Accurate, specific and multi-level identification of proteins and post-translational modifications by LC-HR-MS/MS. Comparative and statistical analyses.
We achieve high sensitivity, selectivity and precision by individually selecting method parameters depending on the drug and expected nitrosamines.
If you want to perform quantitative, qualitative, or mixed LC-MS/MS analyses in a series of samples but don’t have the capabilities – this offer is for you.
Highly specific and sensitive qualitative LC-MS/MS analysis of product composition and supplement contaminants.